Author:
Benyahia Brahim,Brumano Larissa Pereira,Pessoa Adalberto,Santos da Silva Francisco Vitor
Reference225 articles.
1. G. Jagschies, Chapter 1—Disease and healthcare priorities, in: G. Jagschies, E. Lindskog, K. Łącki, P. Galliher (Eds.), Biopharm Process Elsevier, 2018, pp. 3–31, .
2. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990-2013: quantifying the epidemiological transition;Murray;Lancet (London, Engl.),2015
3. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010;Vos;Lancet (London, Engl.),2012
4. Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013;Forouzanfar;Lancet (London, England),2015
5. W. Kaplan, V.J. Wirtz, A. Mantel-Teeuwisse, P. Stolk, B. Duthey, R. Laing, Priority Medicines for Europe and the World 2013 Update, Geneva, 2013, .
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献